ABSTRACT
Current asthma therapy is highly e¡ective in controlling the majority of symptoms if the treatment is taken correctly. As asthma is characterized by abnormal immunological regulation (1), it is likely that this therapy exerts immunomodulatory e¡ects on the airways. However, relatively little is understood about the e¡ect of current antiasthma therapies on immune function and regulation, although the anti-in£ammatory actions of some antiasthma therapies are well described at a clinical level. Understanding more about the immunomodulatory actions of currently used antiasthma treatment is important in developing new therapies for asthma in the future (2,3).
